Facility, planned in Twinsburg, Ohio, will be Hitachi's only R&D facility outside Japan.
Tokyo-based Hitachi Healthcare announced plans this week to create a new research-and-development center at its North American headquarters in Twinsburg, Ohio, later this year, focusing on leveraging artificial intelligence to produce the next generation of imaging technology.
According to a company statement, this facility – the Hitachi Healthcare Innovation Center of Excellence – will establish 40 new jobs in sciences and engineering, setting the stage for closer collaboration with key opinions leaders in the industry. When it opens, it will be the company’s only healthcare research-and-development facility outside Japan.
Currently, Hitachi sells and supports medical imaging devices, including CT, MRI, and ultrasound. In December, the company announced its plans to sell its healthcare division to Fujifilm for $1.6 billion, but, based on the
announcement, that move will not affect activities in Northeast Ohio.
Hitachi’s move to further invest in Northeast Ohio was encouraged by BioEnterprise, a nonprofit organization dedicated to growing Cleveland’s healthcare industry, JobsOhio, and Team NEO. Together, those three groups have injected $55 million into new capital expenditures in Northeast Ohio in the past 18 months. In this latest move, JobsOhio awarded Hitachi Healthcare a Research & Development Grant, and company officials said those funds will be applied to prototyping new equipment, software platforms, and facility upgrades to the Twinsburg facility.
“This R&D investment further demonstrates Hitachi Healthcare’s commitment to design and build the next generation of medical devices, software, and solutions to improve the quality of care in Northeast Ohio,” said J.P. Nauseef, JobsOhio president and chief investment officer, in the press statement.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.